Description de l'entreprise
Baxter and the Baxter International Foundation are committed to saving and sustaining lives and creating healthier communities. The company focuses on three core areas including improving access to healthcare; fostering tomorrow’s innovation and serving its communities. Baxter works closely with public and private partners around the world to ensure people have access to the healthcare they need, to develop the next generation of innovators who will lead the way in advancing care, and to create long-lasting impact in Baxter’s communities. The Baxter International Foundation supports initiatives and organizations that make a positive, lasting impact on increasing access to healthcare for the disadvantaged and underserved.
Conseil d'administration & Conseil de surveillance
| PDG |
| Jose (Joe) E. Almeida |
| Conseil d'administration |
| James Borzi, Stacey Eisen, Darren Evans, Gerard (Jerry) Greco, Tobi Karchmer, Heather Knight, Talvis Love, Jeanne Mason, Reazur (Reaz) Rasul, David S. Rosenbloom, Alok Sonig, Brian Stevens, Chris Toth, Steve Wallace, Daniel (Dan) Wolf |
| Conseil de surveillance |
| Jose (Joe) E. Almeida, William A. Ampofo II, Michael F. Mahoney, Patricia B. Morrison, Ste hen N. Oesterle, Stephen H. Rusckowski, Nancy M. Schlichting, Brent Shafer, Cath R. Smith, Amy A. Wendell, David S. Wilkes, Peter M. Wilver |
Données de l'entreprise
| Nom: |
Baxter International Inc. |
| Adresse: |
One Baxter Parkway,Deerfield, IL 60015, USA |
| Téléphone: |
+1-224-948-2000 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
www.baxter.com |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
73.60% |
| IPO date: |
13/01/1978 |
